|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.95 TWD | +0.58% |
|
-4.42% | -4.77% |
NatureWise Biotech & Medicals Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 160.14 million compared to TWD 228.59 million a year ago. Net income was TWD 10.12 million compared to TWD 30.02 million a year ago.
Basic earnings per share from continuing operations was TWD 0.21 compared to TWD 0.61 a year ago. Diluted earnings per share from continuing operations was TWD 0.2 compared to TWD 0.61 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.77% | 39.43M | |
| +17.03% | 42.2B | |
| +20.78% | 21.24B | |
| +21.40% | 15.89B | |
| +24.36% | 14.91B | |
| +57.38% | 13.1B | |
| -0.05% | 6.79B | |
| -14.94% | 6.24B | |
| +21.38% | 6.08B | |
| -8.87% | 5.73B |
NATUREWISE BIOTECH & MEDICALS CORPORATION 
